Overall survival after surgery for pancreatic cancer in China, 2020–2021 (IMAGE)
Caption
Kaplan-Meier curves for the 6,297 patients who underwent surgery for pancreatic cancer in China, 2020–2021 (China Pancreas Data Center). Left: overall survival for the whole cohort, with median follow-up of 541 days, median overall survival of 798 days and 1-, 2- and 3-year survival rates of 75.8%, 53.3% and 42.0%; right: overall survival by disease stage, with median overall survival not reached for stage I and 775, 560 and 305 days for stages II, III and IV, respectively (stage IV omitted from the plotted curves).
Credit
Wenming Wua, Baiyong Shen, Gang Jin, Xianjun Yu, Yupei Zhao
Usage Restrictions
Commercial use, redistribution or adaptation requires permission from the copyright holders.
License
Original content